Navigation Links
Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
Date:11/9/2007

KIRKLAND, Wash., Nov. 9 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (OTC Bulletin Board: CCYG) announced today that is has received notice of the issuance of a U.S. patent (U.S. Patent No. 7,282,222) for its unique methods and compositions approach to deliver and direct stem cells to target organs in the body.

Using this now-patented technology, exclusively licensed to CellCyte from the US Department of Veterans Affairs, the company is developing stem cell enabling therapeutic products designed to allow more efficient delivery and significantly increased retention of adult stem cells to diseased and other target organs, such as the heart.

Dr. Ronald Berninger, Chief Scientific Officer of CellCyte Genetics explains, "The goal of CellCyte's stem cell targeting/retention therapies is to enhance the number of cells available for regeneration of damaged tissue, and thereby markedly increase opportunities for healing and restoring organ function. The company's first product in development, CCG-TH30, is designed to target autologous bone-marrow-derived (adult) stem cells to the heart of patients after a heart attack."

"In preclinical models, CCG-TH30 has been shown to increase the retention of stem cells up to as much as 77% in pre-clinical models as compared to conventional methods, which achieve only up to about 6%," Berninger states. "Importantly, CellCyte's product candidate, along with stem cells, can both be delivered intravenously through a patient's circulatory system without an invasive procedure."

Company CEO, President and Chairman, Gary A. Reys emphasizes the importance of the patent's issuance to the company's position. Reys states, "This patented technology is significant, as it has the potential to fill an important missing piece in the field of regenerative medicine, namely, the ability to target and then keep cells in an organ of interest, in this case, the heart. The issuance of a patent for this platform assures
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...GARYandBLENHEIM,Ontario,Nov.24/PRNewswire-FirstCal...ngtheassetsofHylandSeeds,adivisionofThompsonsLimit...urtherexpandDowAgroSciences,currentseedsbusinessas...M) in 2010 andDowAgroSciencesHerbicideTolerantTr...xpectedinthenearfuture. ,, "Thisacquisitionbrin...
(Date:11/24/2009)...NGHAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsI...asallowedthepatentapplicationfor,itsnano-particleo...ahighlyefficientapproachtoincorporatepeptidesor,pr...liveryofdrugs,otherwiseadministeredasinjections.NO...omanymacromoleculardrugssuchasinsulin,interferon,...
(Date:11/24/2009)...maryefficacyendpointhasbeenmetforpatientswithadvan...BECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZentar...lbiopharmaceuticalcompanyfocusedonendocrinetherapy...aPhase2studywithitstargetedcytotoxicpeptideconjuga...orrecurrentendometrialcancer.Inapersonalizedhealth...
(Date:11/24/2009)...EN,Italy,November24/PRNewswire/--HealthRoboticstod...ewithagroupofselected,investors.Thisrecentlyformed...RoboticsCanada,Inc.andwillmarket,install,andsuppor...ncludesthe,revolutionaryproductofferingsi.v.STATIO...aInc.willalsoprovideassistanceonan"asneeded,basis"...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
... Mixed-Pedigree Pups Can Now Bark Up Family Tre...Diego (PRWEB) July 10, 2008 -- Barking up the fami...e DNA testing for mixed-pedigree pups now availabl...ng pet specialty retailer., , , , ,Beginning Tuesd...ase the Canine Heritage Breed Test (CHBT) and the ...
...stic policy areas that the new administration must... than nanotechnology a new technology that has be...s of its impact on society. If the right decisions...ents to almost every area of daily living. If the ...man health and the environment will suffer. , Na...
... /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VS...ions for the,three and six months ended May 31, 20...nadian dollars unless otherwise noted., At May 31...4 million,compared with $19.9 million at February ... 2008 was $7.4 million, or $0.33,per common share,...
Other Biology Technology:PETCO Adds Canine Heritage Breed Test to its Innovative Assortment 2PETCO Adds Canine Heritage Breed Test to its Innovative Assortment 3PETCO Adds Canine Heritage Breed Test to its Innovative Assortment 4Vasogen Announces Second Quarter 2008 Results 2Vasogen Announces Second Quarter 2008 Results 3Vasogen Announces Second Quarter 2008 Results 4Vasogen Announces Second Quarter 2008 Results 5Vasogen Announces Second Quarter 2008 Results 6Vasogen Announces Second Quarter 2008 Results 7Vasogen Announces Second Quarter 2008 Results 8Vasogen Announces Second Quarter 2008 Results 9Vasogen Announces Second Quarter 2008 Results 10
(Date:11/24/2009)...otein that may help gut bacteria bind to the gastr...obiotic producers to identify strains that are lik...s need to interact with cells lining the gut to ha...aces in the gut they are more likely to stick arou...athalie Juge from the Institute of Food Research. ...
(Date:11/24/2009)...g held secrets of the earth,s history locked in it...ery little information on the environments that ha...f years. Now, a team of researchers from nine inst...une of $10 million dollars by the National Science...s literally. These scientists will drill through ...
(Date:11/23/2009)...ssociated strain of the deadly superbug MRSAan inf...ntibioticsposes a far greater health threat than p...ls, according to a study in the December issue of ...t is easily picked up in fitness centers, schools,...rall burden of MRSA within hospitals, the report f...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Fingertip Formulary Accounts 28R 29 Now Offers Access to Comprehensive Real Time Account Information and Integrated Formulary Data in a State of the 52885 1Fingertip Formulary Accounts 28R 29 Now Offers Access to Comprehensive Real Time Account Information and Integrated Formulary Data in a State of the 52885 2AHIMA Enters Multinational Arena to Support HIM Worldwide Advancement 52881 1AHIMA Enters Multinational Arena to Support HIM Worldwide Advancement 52881 2AHIMA Enters Multinational Arena to Support HIM Worldwide Advancement 52881 3Ten Secrets for Getting High Quality Plastic Surgery at More Affordable Prices 52877 1Ten Secrets for Getting High Quality Plastic Surgery at More Affordable Prices 52877 2Ten Secrets for Getting High Quality Plastic Surgery at More Affordable Prices 52877 3
...f chromosomes snuggle up too closely at the wrong ...w researchers have found the molecular machines in...ng structures, apart when necessary. , The machi...somes by twisting them into supercoils that kink u... had known of condensin II but did not know how it...
...ientists at St. Jude Children,s Research Hospital ... cancer cells of children with acute lymphoblastic...fers a pathway to designing treatments for ALL rel...e most common childhood cancer, ALL affects thousa...hough more than 80 percent of ALL cases are cured,...
...RVALLIS, Ore. In the same way that winter is comm...gests that the dog days of summer may well be the ...discovered that serious infections caused by gram-...with every 10 degree increase in seasonal temperat... of data from infections in a Baltimore hospital, ...
Other Biology News:Keeping chromosomes from cuddling up 2Keeping chromosomes from cuddling up 3St. Jude identifies genomic causes of a certain type of leukemia relapse 2St. Jude identifies genomic causes of a certain type of leukemia relapse 3Winter brings flu, summer brings bacterial infections 2
CORNING VOLUME ADAPTER FOR 96 WELL PLATES from Sigma-Aldrich
Rabbit Anti-BMP2 Polyclonal Antibody, Unconjugated from GeneTex
... Antibody against TATA Binding Proteins (TBP). Asc...t human TBP and recognizes amino acids 41-57 and m...mentation of TBP occurs. This antibody does not i...uclear extract or as a minimal activity extract) i...
...-Sealer is a manual heat sealer ideal for low to m...rtable instrument can seal a wide range of plates ...ers. The heating element of the sealer is pre-set ...t or peelable seals when used in conjunction with ...
Biology Products: